Skip to main content

Table 3 Mean (SD) and Median (IQR) baseline characteristics in all randomised participants (intention to treat population)

From: The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trial

Characteristic

N

N = 75a

Sex

75

 

 Male

 

33 (44%)

 Female

 

42 (56%)

Age at registration

75

58 (14), 58 (50, 69)

Ethnicity

75

 

 White

 

42 (56%)

 Asian

 

15 (20%)

 Black

 

16 (21%)

 Mixed

 

1 (1.3%)

 Other

 

1 (1.3%)

Smoking status

71

 

 Current smoker

 

6 (8.5%)

 Ex-smoker

 

12 (17%)

 Non-smoker

 

53 (75%)

Main cause of renal failure

74

 

 Diabetic nephropathy

 

12 (16%)

 Glomerular disease

 

2 (2.7%)

 Hypertension

 

20 (27%)

 Tubulointerstitial disease

 

3 (4.1%)

 Renovascular disease

 

1 (1.4%)

 Polycystic kidney disease

 

11 (15%)

 Other

 

16 (22%)

 Unknown cause

 

9 (12%)

History of kidney transplantation

69

3 (4.3%)

History of myocardial infarction

74

2 (2.7%)

History of ischemic heart disease

74

5 (6.8%)

History of stroke/TIA

74

1 (1.4%)

History of heart failure

74

0 (0%)

History of peripheral vascular disease

74

2 (2.7%)

History of atrial fibrillation

74

0 (0%)

History of hypertension

74

50 (68%)

History of diabetes

74

22 (30%)

History of cancer (excluding skin cancers)

74

4 (5.4%)

History of hyperlipidaemia

74

26 (35%)

  1. an (%); Mean (SD), Median (IQR)